FARMINGTON, Conn. , April 18, 2023 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") (the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science,...
- Horizon Platform Originates $47 Million of New Loans in Q1, Including $40 Million of New Loans for HRZN - - Horizon Platform Ends Quarter with Committed Backlog of $218 Million , Including $187 Million in HRZN Commitments - FARMINGTON, Conn. , April 12, 2023 /PRNewswire/ -- Horizon...
FARMINGTON, Conn. , Feb. 28, 2023 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") (the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare...
- Fourth Quarter 2022 Net Investment Income per Share of $0.40 ; NAV per Share of $11.47 - - Grew Portfolio Year over Year by 57% to Record $720 Million - - Horizon Platform Ends 2022 with Committed Backlog of $255 Million , Including $220 Million in Horizon Commitments - - Annual Debt Portfolio...
FARMINGTON, Conn. , Feb. 23, 2023 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon" or the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science,...
FARMINGTON, Conn. , Feb. 14, 2023 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") (the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare...
- Horizon Platform Originates $114 Million of New Loans in Q4, Including $104 Million of New Loans for HRZN - - HRZN Grows Loan Portfolio by $262 Million in 2022 - - Horizon Platform Ends 2022 with Committed Backlog of $255 Million , Including $220 Million in HRZN Commitments - FARMINGTON, Conn....
CAMBRIDGE, Mass., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered medicines acting on the small intestinal axis, SINTAX, today announced it has entered into a senior secured loan...
FARMINGTON, Conn. , Nov. 29, 2022 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and...
Issued $100 Million of Notes with a Fixed Interest Rate of 7.56% Rated A by a rating agency FARMINGTON, Conn. , Nov. 14, 2022 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon" or the "Company"), a leading specialty finance company that provides capital in the form of...
